Plant-Based Diet for Patients With Rheumatoid Arthritis

NCT07268326 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2026-03-18

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the effect of a plant-based diet (PBD) intervention in adults with Rheumatoid Arthritis (RA) on disease activity.

The investigators hypothesize that if patients with RA follow a 100% PBD over a 16-week period it will lead to improvements in:

\- Disease activity (measured by DAS28), including reduction in symptoms and overall improvements in health-related quality of life.

The effects of the PBD will be compared to a habitual diet, that includes no dietary changes.

Participants in the intervention group will:

* Receive weekly delivery of food boxes which include plant-based food items
* Receive a daily multivitamin supplement
* Receive continuous dietetic guidance
* Participate in a practical cooking class to get an introduction to a PBD
* Participate in three online supervisions throughout the intervention period

Participants in the control group will follow the same plan for the project visits at the hospital but will be restricted to continue their habitual diet. Thus, not performing any dietary changes.

Conditions

  • Rheumatoid Arthritis (RA)

Interventions

OTHER

Plant-based diet

The intervention is a 100% plant-based diet, and a daily multivitamin supplement. Participants in the intervention group will receive weekly food delivery to their household. Moreover, they will participate in a practical cooking workshop with other participants of the intervention group. Furthermore, they will have three online supervisions with relevant project staff.

Sponsors & Collaborators

  • Glostrup University Hospital, Copenhagen

    collaborator OTHER
  • Center for Clinical Research and Prevention

    lead NETWORK

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-15
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07268326 on ClinicalTrials.gov